TuisPFE • NYSE
add
Pfizer Inc
Vorige sluiting
$25,13
Dagwisseling
$25,10 - $25,75
Jaarwisseling
$24,48 - $31,54
Markkapitalisasie
145,36 mjd USD
Gemiddelde volume
45,27 m
P/V-verhouding
34,67
Dividend-opbrengs
6,55%
Primêre beurs
NYSE
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 17,70 mjd | 31,20% |
Bedryfskoste | 6,99 mjd | 0,26% |
Netto inkomste | 4,46 mjd | 287,45% |
Netto winsgrens | 25,22 | 242,89% |
Wins per aandeel | 1,06 | 723,53% |
EBITDA | 7,59 mjd | 1 012,88% |
Effektiewe belastingkoers | 4,96% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 9,95 mjd | -77,47% |
Totale bates | 219,48 mjd | 2,07% |
Totale aanspreeklikheid | 126,92 mjd | 7,72% |
Totale ekwiteit | 92,56 mjd | — |
Uitstaande aandele | 5,67 mjd | — |
Prys om te bespreek | 1,54 | — |
Opbrengs op bates | 6,70% | — |
Opbrengs op kapitaal | 9,17% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 4,46 mjd | 287,45% |
Kontant van bedrywe | 6,71 mjd | 94,27% |
Kontant van beleggings | -2,06 mjd | -331,64% |
Kontant van finansiering | -4,64 mjd | -22,68% |
Netto kontantverandering | 29,00 m | -94,58% |
Beskikbare kontantvloei | 3,35 mjd | 174,32% |
Meer oor
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine, apixaban, a pneumococcal conjugate vaccine, palbociclib, and tafamidis. In 2023, 46% of the company's revenues came from the United States, 6% came from Japan, and 48% came from other countries.
The company ranks 38th on the Fortune 500 and 39th on the Forbes Global 2000. Wikipedia
Gestig
1849
Webwerf
Werknemers
88 000
